Investigative Alert: Faruqi & Faruqi, LLP Reviews Investor Claims Against QuidelOrtho Corporation (QDEL)

NEW YORK, May 22, 2024— National securities law firm Faruqi & Faruqi, LLP is spearheading an investigation into potential claims on behalf of investors in QuidelOrtho Corporation QDEL. Shareholders are being prompted to consider participating ahead of the June 11, 2024 deadline to pursue the role of lead plaintiff in a case involving the company.

Background on QuidelOrtho and the Investigation

QuidelOrtho, a company specializing in the development, manufacturing, and marketing of diagnostic testing solutions, is at the center of a probe relating to its business practices. The availability of a variety of tests for infectious diseases, cardiology, and other health-related fields has positioned QuidelOrtho as a key player in the diagnostic sector. With its headquarters rooted in San Diego, California, the company has established a broad global presence.

Despite these positive business aspects, investors are encouraged to remain vigilant, as legal inquiries like the one undertaken by Faruqi & Faruqi, LLP can uncover practices that may affect investor interests. The investigation by the law firm intends to determine whether the management of QuidelOrtho has engaged in activities detrimental to shareholder value.

Investor Participation and Lead Plaintiff Deadline

Investors who purchased shares of QuidelOrtho QDEL and are interested in taking on a more prominent role in litigation are reminded of the approaching deadline. Potential plaintiffs should evaluate their eligibility and consider acting before June 11, 2024. Taking on the mantle of lead plaintiff is subject to certain criteria and is typically reserved for those who have experienced significant losses attributable to the misdeeds of the company in question. The role entails working closely with legal counsel to assert the rights of the shareholder group.

It is the duty of law firms like Faruqi & Faruqi, LLP to inform and assist investors in times when financial disclosure or corporate governance issues are at stake. The pursuit of accountability and transparency is not only for the benefit of individual investors but for the stability and integrity of the broader market.

investigation, legal, shareholders